Logo image of ALLIX.PA

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

EPA:ALLIX - Euronext Paris - Matif - FR0010131409 - Common Stock - Currency: EUR

17.12  +0.42 (+2.51%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALLIX. ALLIX was compared to 102 industry peers in the Software industry. Both the profitability and financial health of ALLIX have multiple concerns. ALLIX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALLIX had negative earnings in the past year.
ALLIX had a positive operating cash flow in the past year.
In the past 5 years ALLIX always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALLIX reported negative operating cash flow in multiple years.
ALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

With a Return On Assets value of -7.92%, ALLIX is not doing good in the industry: 68.63% of the companies in the same industry are doing better.
With a Return On Equity value of -43.66%, ALLIX is not doing good in the industry: 77.45% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.92%
ROE -43.66%
ROIC N/A
ROA(3y)-11.42%
ROA(5y)-10.74%
ROE(3y)-44.79%
ROE(5y)-35.26%
ROIC(3y)N/A
ROIC(5y)N/A
ALLIX.PA Yearly ROA, ROE, ROICALLIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

ALLIX has a Gross Margin of 113.33%. This is amongst the best in the industry. ALLIX outperforms 98.04% of its industry peers.
In the last couple of years the Gross Margin of ALLIX has remained more or less at the same level.
ALLIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 113.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
ALLIX.PA Yearly Profit, Operating, Gross MarginsALLIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

More info and screens

1

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALLIX has a better debt/assets ratio than last year.
ALLIX.PA Yearly Shares OutstandingALLIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALLIX.PA Yearly Total Debt VS Total AssetsALLIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 0.56, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.
ALLIX's Altman-Z score of 0.56 is on the low side compared to the rest of the industry. ALLIX is outperformed by 76.47% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that ALLIX is somewhat dependend on debt financing.
ALLIX's Debt to Equity ratio of 0.81 is on the low side compared to the rest of the industry. ALLIX is outperformed by 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACCN/A
WACC8.36%
ALLIX.PA Yearly LT Debt VS Equity VS FCFALLIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.88 indicates that ALLIX may have some problems paying its short term obligations.
ALLIX's Current ratio of 0.88 is on the low side compared to the rest of the industry. ALLIX is outperformed by 77.45% of its industry peers.
ALLIX has a Quick Ratio of 0.88. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALLIX (0.88) is worse than 75.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
ALLIX.PA Yearly Current Assets VS Current LiabilitesALLIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

ALLIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.55%, which is quite impressive.
Looking at the last year, ALLIX shows a quite strong growth in Revenue. The Revenue has grown by 12.96% in the last year.
ALLIX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.85% yearly.
EPS 1Y (TTM)47.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140.34%
Revenue 1Y (TTM)12.96%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%16.63%

3.2 Future

ALLIX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.88% yearly.
ALLIX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.69% yearly.
EPS Next Y107.79%
EPS Next 2Y77.28%
EPS Next 3Y57.88%
EPS Next 5YN/A
Revenue Next Year21.88%
Revenue Next 2Y22.98%
Revenue Next 3Y17.69%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALLIX.PA Yearly Revenue VS EstimatesALLIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALLIX.PA Yearly EPS VS EstimatesALLIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALLIX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 277.02, which means the current valuation is very expensive for ALLIX.
Based on the Price/Forward Earnings ratio, ALLIX is valued a bit more expensive than 64.71% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, ALLIX is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 277.02
ALLIX.PA Price Earnings VS Forward Price EarningsALLIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALLIX.PA Per share dataALLIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALLIX does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ALLIX's earnings are expected to grow with 57.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.28%
EPS Next 3Y57.88%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALLIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WALLIX GROUP

EPA:ALLIX (6/17/2025, 7:00:00 PM)

17.12

+0.42 (+2.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-20 2025-03-20/amc
Earnings (Next)07-17 2025-07-17
Inst Owners11.9%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap114.02M
Analysts84
Price Target17.85 (4.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)140%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 277.02
P/S 3.34
P/FCF N/A
P/OCF 73.56
P/B 11.59
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)0.06
Fwd EY0.36%
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)0.23
OCFY1.36%
SpS5.12
BVpS1.48
TBVpS-1.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.92%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 113.33%
FCFM N/A
ROA(3y)-11.42%
ROA(5y)-10.74%
ROE(3y)-44.79%
ROE(5y)-35.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 149.87%
Cap/Sales 18.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z 0.56
F-Score5
WACC8.36%
ROIC/WACCN/A
Cap/Depr(3y)134.63%
Cap/Depr(5y)153.59%
Cap/Sales(3y)19.11%
Cap/Sales(5y)22.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140.34%
EPS Next Y107.79%
EPS Next 2Y77.28%
EPS Next 3Y57.88%
EPS Next 5YN/A
Revenue 1Y (TTM)12.96%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%16.63%
Revenue Next Year21.88%
Revenue Next 2Y22.98%
Revenue Next 3Y17.69%
Revenue Next 5YN/A
EBIT growth 1Y40.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.43%
EBIT Next 3Y66%
EBIT Next 5YN/A
FCF growth 1Y40.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y144.57%
OCF growth 3Y-37.14%
OCF growth 5YN/A